发明名称 SULFONAMIDE DERIVATIVE
摘要 <p>A compound represented by the formula (1) [A represents a nitrogen-containing saturated ring; m represents an integer of 0 to 2; n represents an integer of 1 to 4; G 1 represents hydrogen atom, chlorine atom, hydroxyl group, an alkoxy group, or amino group; G 2 represents a halogen atom, hydroxyl group, cyano group, carboxy group, an alkyl group, an alkenyl group, an alkynyl group, an alkoxy group, an alkylthio group, an amino group, an alkylsulfinyl group, an alkylsulfonyl group, or an aryl group; G 3 represents hydrogen atom, a halogen atom, hydroxyl group, cyano group, carboxy group, an alkyl group, an alkenyl group, an alkynyl group, an alkoxy group, an alkylthio group, an amino group, an alkoxycarbonyl group, an acyl group, an acyloxy group, an alkylsulfinyl group, an alkylsulfonyl group, or an aryl group; Y represents a single bond, or -C(R 3 )(R 4 )- (R 3 and R 4 represent hydrogen atom, or an alkyl group, or alkylene groups which combine together to form a saturated hydrocarbon ring group); G 4 represents hydroxyl group (Y is a single group), or - N(R 1 )(R 2 ) (R 1 and R 2 represent hydrogen atom, an alkyl group, an aralkyl group, an alkenyl group, an alkynyl group, a saturated heterocyclic group, an alkylsulfonyl group, an acyl group, or an amidino group); G 5 is a substituent on a ring-constituting carbon atom of A, and represents hydrogen atom, fluorine atom, or an alkyl group] or a salt thereof, or a derivative thereof that is a prodrug, which potently inhibits Rho kinase.</p>
申请公布号 EP2130828(A1) 申请公布日期 2009.12.09
申请号 EP20080720915 申请日期 2008.02.27
申请人 ASAHI KASEI PHARMA CORPORATION 发明人 MATSUBARA, KOKI;IESATO, ATSUSHI;OOMURA, AKIFUMI;KAWASAKI, KOH;YAMADA, RINTARO;SETO, MINORU
分类号 C07D401/12;A61K31/382;A61K31/433;A61K31/4725;A61K31/5377;A61K31/542;A61K31/551;A61K31/5575;A61K45/00;A61P19/00;A61P25/00;A61P27/06;A61P29/00;A61P43/00;C07D401/14;C07D405/14;C07D409/14;C07D413/14;C07D487/04 主分类号 C07D401/12
代理机构 代理人
主权项
地址